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NDP01:
LONG-TERM OUTCOME OF NEPHROURETRECTOMY IN DIALYSIS
PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA
Ta-Yao Tai, Chien-Hui Ou. Department of Urology, National Cheng Kung
University Hospital, Tainan, Taiwan
Purpose: Nephroureterectomy and bladder cuff resection is a standard
surgical management for patients with upper tract urothelial carcinoma
(UTUC). However, the long-term survival outcomes in dialysis patients is
insufﬁcient throughout literature.
The present study is the ﬁrst large cohort study to discuss the outcomes of
dialysis patients with upper tract urothelial cell carcinoma (UTUC) who
received nephroureterectomy, with a long-term follow-up. These out-
comes provide further evidence suggesting that nephroureterectomy with
bladder cuff resection is a feasible strategy and providing effective onco-
logical control of dialysis patients with UTUC in an experienced center.
To report the long-term outcomes of dialysis patients with upper tract
urothelial cell carcinoma (UTUC) who received nephroureterectomy at a
single institution over a 10-year period.
Materials and Methods: Patients who underwent nephroureterectomy
between November 2003 and November 2013 were identiﬁed from Na-
tional Cheng Kung University Hospital (NCKUH), a tertiary medical center
in Taiwan. Outcomes were obtained via retrospective analysis of notes and
electronic records. Overall survival (OS), cancer-speciﬁc survival (CSS) and
recurrence-free survival (RFS) were estimated using KaplaneMeier
methods and grade-stratiﬁed differences were analyzed using the log-rank
test.
Results: Between November 2003 and November 2013, 270 patients un-
derwent nephroureterectomy of UTUC with a median age at diagnosis of
68 years. Median (range; mean) follow-up was 29 (2e120; 35.3) months.
In total, 23.3% (n ¼ 63) of the patients underwent dialysis. In general,1879-5226/ Copyright © 2015, Taiwan Urological Association. Published by Elsevier Ta
creativecommons.org/licenses/by-nc-nd/4.0/).dialysis patients were younger, and had better pathological stage, tumor
grade and lymphovascular invasion. The estimated OS in non-dialysis
group and dialysis group were 70% and 84%, respectively, at 5 years, and
57% and 60%, respectively, at 10 years (p ¼ 0.2187). The estimated mean
RFS in non-dialysis patients and dialysis patients was 67.6% and 68.3%,
respectively at 5 years.
Conclusion: In this present single center cohort study, nephroureter-
ectomy in dialysis patients with UTUC was feasible and could provide
effective oncological control.
NDP02:
EPITHELIOID ANGIOMYOLIPOMA OF KIDNEYdREPORT OF NINE CASES
AND LITERATURE REVIEW
Ming-Hsuan Ku1, Tzu-Ping Lin 1,2,3, Hsiao-Jen Chung 1,2,3, Shing-Hwa
Lu 1,2,3, Yen-Hua Chang 1,2,3, Tai-Wai Chin 4, Chin-Chen Pan 5, Alex Tong-
Long Lin 1,2,3, Kuang-Kuo Chen 1,2,3. 1Department of Urology, Taipei
Veterans General Hospital, Taiwan; 2 School of Medicine, National Yang-
Ming University, Taiwan; 3 Shu-Tien Urological Institute, National Yang-
Ming University, Taiwan; 4Department of Surgery, Taipei Veterans General
Hospital, Taiwan; 5Department of Pathology, Taipei Veterans General
Hospital, Taiwan
Purpose: Several morphologic variants of Angiomyolipoma (AML) have
been described in literature, including epithelioid, oncocytic, fat-pre-
dominant, smooth muscle-predominant, AML with sclerosing cysts and
sclerosing types. Among these variant types of AML, epithelioid type is
rare, and regarded as potentially malignant mesenchymal neoplasms. We
reviewed our pathology database from January. 2008 to August. 2015, and
9 cases of epithelioid AML were found. Here we present their disease
courses, and outcome.
Materials and Methods:iwan LLC. This is an open access article under the CC BY-NC-ND license (http://
 Age/ sex Tumor size (cm)  Initial symptoms Comorbidity Final diagnosis Epithelioid 
cells (%) 
1 12/ F 3 x 2.7 x1.2 Asymptomatic Epithelioid AML 100 
2 54/ F 4.3 x 4.2x 4.0 Asymptomatic Epithelioid AML 100 
3 54/ F 15 x 12 x 8 Asymptomatic Tuberous sclerosis Epithelioid AML 100 
4 78/ M 6 x 5.7 x 4.8 Asymptomatic Epithelioid AML 100 
5 42/ F 5.8 x 5.5 x 5 Asymptomatic AML with focal atypical 
epithelioid cells 
<50 
6 34/ F 7.5 x 7 x 6 Asymptomatic AML with focal epithelioid 
feature (20%) and atypia 
20 
7 73/ M 17 x 13 (in CT) Lt flank pain for 6 
months; BW loss 10 kg 
in 6 months 
Cancer of stomach,  
pT1N0(0/40)M0, 
stage IA s/p 
RSG+Roux-enY, 2 
years before renal 
tumor diagnosed 
Malignant Epithelioid AML 100 
8 54/ M 16 x 13 x 13 Palpable mass over 
abdomen 
Lt adrenal 
pheochromocytoma, 
s/p adrenalectomy 
at the same time of 
Lapa. RN 
Malignant Epithelioid AML 100 
9 31/ F 14.5 x 11 x 
10 
Low grade fever, poor 
appetite for 2 months 
Ankylosing  
spondylosis 
Malignant Epithelioid AML 100 
 Surgical 
procedure 
Local 
invasion 
Surgical 
Margins 
LN 
metastase
s 
Distant 
metastases 
F/u 
(month) 
Medical 
therapy 
Outcome 
1 Lt OPN Nil Free Nil (-) 40 Nil Alive, NED; loss of f/u 
2 Lt Lapa. RN Nil Free Nil (-) 76 Nil Alive, NED 
3 Lt ORN Nil Free (+), 
deposits 
of classic 
AML 
suspicious 
lung  and 
bone lesions  
10 Nil Alive, doing well during 
follow-up period, with 
non-progressive lung 
lesions; loss of f/u 
4 Rt Lapa. RN Sinus fat Free Nil (-) 3 Nil Alive, NED 
5 Rt Robotic PN Nil Free (-) (-) 23 Nil Alive, NED 
6 Rt OPN Nil Free (-) (-) 18 nil Alive, NED 
7 nil stomach, 
pancreas, 
spleen, Lt 
adrenal gland  
Nil (+) (+) Lung, 
Left thigh 
5 Sirolimus for 
2 months 
Died of disease 
progression 
8 Lt lapa. RN Renal sinus, 
collecting 
system and 
renal 
vascular  
Free (-) (-) 2 nil Alive, NED 
9 Lt ORN + 
renal hilar LN 
dissection 
Nil Free (-) (+) Multiple 
lung mets, 
Lt adrenal 
gland, brain 
metastasis 
16 Adjuvant 
therapy with 
Temsirolimus 
,sirolimus , 
chemotherapy 
With brain, lung 
metastasis.  
Loss of follow-up after 
16 months
Ă
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phrectomy; ORN, open radical nephrectomy; lapa., laparoscopic ; NED, no
evidence of disease; AML, angiomyolipoma; RSG, radical subtotal
gastrectomy
Conclusion: Among these 9 cases, 2 cases (22.2%) had distant metastases
and ominent outcome. 3 cases with symptoms (ﬂank pain, palpable mass,
body weight loss) were all diagnosed as malignant epithelioid AML, indi-
cating symptomatic renal tumor may need to be managed more cautiously
as potential malignancies.
NDP03:
EXPLORE THE CHARACTERISTICS OF BLADDER FUNCTION OF THE
PATIENTS WITH PELVIC ORGAN MALIGNANCY
Chian-Shiung Lin 1,2, Chih-Cheng Lu 1, Chia-Ho Lin 1, Eric W. Fan 1, Tse-Chou
Cheng 1. 1Divisions of Urology, Department of Surgery, Chi Mei Medical
Center, Liouying, Tainan City, Taiwan; 2Min-Hwei Junior College of Health
Care Management, Tainan City, Taiwan
Purpose: The primary function of urinary bladder is for urine storage and
voiding. Pelvic organ malignancy may deteriorate the originally normal
bladder function via either neurogenic or myogenic way. The aim of this
study is to compare urodynamic bladder dysfunction among the patients
with different pelvic organ malignancies.
Materials and Methods: From January 2010 to June 2015, there were 640
patients eligible for urodynamic analysis. Patients were stratiﬁed into 3
groups based on cancer origins (prostate, bladder, and colorectum). The
data including gender, age, clinical tumor staging, lower urinary tract
symptoms or acute urinary retention, and the parameter values of uro-
dynamic studies were compared among groups. SPSS 17.0.1 for Windows
and Microsoft Ofﬁce Excel 2007 were used for all statistical analysis.
Results: Pelvic organ malignancies included prostatic (40.9%), bladder
(33.5%), and colorectal (25.6%) origin. Age ranged from 39 to 95 years
(mean 72.93± 9.08 years). In uroﬂowmetry (525 cases), the mean± -
standard deviation of maximal urine ﬂow rate was signiﬁcant lower in
prostatic group (11.49± 5.53 ml/sec). In cystometrogram (115 cases), the
ﬁrst desire was more sensitive in bladder group (85.52± 49.78 ml); the
cystometric capacity was obvious decreased in prostatic group
(161.50± 94.29 ml); the maximum voiding pressure and compliance were
signiﬁcant lower in colorectal group (64.58± 50.09 cmH2O).
Conclusions: Patients having pelvic organ malignancies may suffer from
urination dysfunction. Urinary ﬂow rate obvious decreased in prostate
group, more hypersensitive bladder was found in bladder group and
bladder dysfunction was poor in colorectal group. The physicians are
encouraged to be aware of these urinary complications in patient with
pelvic organ oncology.
NDP04:
THE PATTERN OF CALCIFICATION CAN PREDICT THE TYPE OF
MALIGNANCY IN UPPER URINARY TRACT
Li-Hua Huang 1, Chuan-Shu Chen 2, Yen-Chuan Ou 2. 1Divisions of Urology,
Department of Surgery, Tungs' Taichung MetroHarbor Hospital, Taichung,
Taiwan; 2Divisions of Urology, Department of Surgery, Taichung Veterans
General Hospital, Taichung, Taiwan
Purpose: In upper urinary tract (UUT), squamous cell carcinoma(SCC) and
urothelial carcinoma (UC) are twodifferent disease in its etiology, incidence
and prognosis. I contrast to UC, the development SCC is believed to bemore
related to chronic inﬂammation of urothelial epithelium secondary to renal
calculi. In this study, we investigated the relationship between calciﬁcation
patternandsquamousneoplasminupperurinarytract.
Materials and Methods: The study was approved by institutional review
board. From 2000 to 2007, there are 373 patients with localized upper
urinary tract malignancy receiving radical nephroureterectomy with
bladder cuff excision (RNU) at Taichung Veterans General Hospital. Only
patients having UC, UC with squamous differentiation (SqD) and SCC were
enrolled. These patients' clinical and pathologic data were retrospectively
reviewed. The calciﬁcation pattern in tumors was analyzed by computer
tomography(CT). Among these, 62 patients' preoperative CT ﬁlms were
lost and they were excluded from the study. Finally, there were 232 pureUC, 24 UC with SqD and 9 pure SCC(2.7%) patients. The differences of
calciﬁcation pattern were analyzed by Fisher's exact test and chi- square
test (Categorical variables). Continuous variables were asscssed by Mann-
Whitney-U (two categories) and Kruskal-Wallis tests (three categories)
Results: Computer tomography shows the rates of calciﬁcation change are
7.8% (18/232), 25.0% (6/24) and 55.6% (5/9) in UC, SqD and SCC, respec-
tively. In SCC, the calciﬁcation tends to be bigger, and more numerous. In
addition, all SCC patients had multifocal distribution of calciﬁcation while
SqD and UC patients often had single calciﬁcation.
Conclusions: We can predict the type of tumor in upper urinary tract
according to the calciﬁcation pattern at CT. When CT revealed multiple,
dispersive and bigger calciﬁcation in the tumor, squamous cell carcinoma
should be considered and the surgical ﬁeld should be more extended.
NDP05:
VARIATIONS OF CLINICAL PRACTICE GUIDELINES BETWEEN CHINA AND
TAIWAN IN ROBOT-ASSISTED LAPAROSCOPIC RADICAL
PROSTATECTOMY
Chih-Cheng Lu, Wen-Chou Fan. Division of Urology, Department of Surgery,
Chi Mei Medical Center, Liouying, Tainan, Taiwan
Purpose: To explore the role of robot-assisted Laparoscopic radical pros-
tatectomy (RALP) from the documented clinical practice guidelines (CPGs)
between China and Taiwan.
Materials andMethods: The printed and onlinematerials in guidelines for
PCa from China and Taiwan were analyzed. We focused on the RALP
treatment for PCa.
Results: The online guidelines for PCa by Chinese Urological Association
(CUA)were available in 2011(since 2007 as the ﬁrst version). Taiwanese ﬁrst
version was available by Taiwan Cooperation Oncology Group (TCOG) PCa
practice guidelines in 1999, the second edition in 2003, and the third edition
in 2010. Normal range of prostate speciﬁc antigen (PSA) is deﬁned from
Chinese people datawith age speciﬁc consideration in CUA, but not inTCOG.
PCa Staging by AJCC 2002 is noted in CUA but by AJCC 2010 (the seventh
edition) in TCOG. In treatment, RALP takes the advantage of less blood loss
and blood transfusion rate compared with traditional approach in both
CPGs. Some signiﬁcant improvement in postoperative urinary control
compared with traditional approach in TCOG but no conclusions in CUA.
Better outcome in sexual function from RALP in TCOG but not in CUA. High
installment cost is mentioned in both CPGs. No Deﬁnite evidence-based
level of evidence or grade of recommendation is mentioned in both CPGs.
Conclusion: There are differences in staging system, merits of RALP
treatment between China and Taiwan in CPGs. Also this limited study
could do some help for the revision of the CPG in Taiwan. Asian urologists
and oncologists are suggested to realize the differences at managing
prostate cancer patients.
NDP06:
INFLAMMATORY MYOFIBROBLASTIC TUMOR OF URINARY BLADDER IN
A PATIENT WITH HUMAN IMMUNODEFICIENCY VIRUS e A RARE CASE
REPORT AND LITERATUR REVIEW
Wei-Jen Chen 1, Chih-Chieh Lin 1,2,3, Alex T.L. Lin 1,2,3, Kuang-Kuo
Chen 1,2,3. 1Department of Urology, Taipei Veterans General Hospital,
Taiwan; 2Department of Urology, School of Medicine, National Yang-Ming
University, Taiwan; 3 Shu-Tien Urological Science Research Center, Taiwan
Purpose: Inﬂammatorymyoﬁbroblastic tumor (IMT) is a rare tumor with a
generally indolent, but sometimes aggressive behavior. It had been
described inmajor organs. The ﬁrst case of IMTof the bladder was reported
in 1980. Until recent 15 years, IMT have gained a distinct entity with
established characteristic features in pathological diagnosis. Reported lit-
eratures are limited in case report and case series. A systemic review article
published in 2014 presented a total of 182 patients with IMT in urinary
bladder. However, there is no related literature in patient with human
immunodeﬁciency virus (HIV). Here, we report a HIV patient with IMT of
the urinary bladder and discuss its clinical presentation, diagnosis and
management.
Materials and Methods: A 45 year-old HIV infected man, came to our
outpatient department due to painless gross hematuria with repeated
